UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, DC 20549
FORM 8-A
FOR REGISTRATION
OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO
SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ENDRA LIFE SCIENCES INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
(State of incorporation or organization)
|
26-0579295
(I.R.S. Employer Identification No.)
|
|
3600 Green Court, Suite 350
Ann Arbor, MI
|
48105
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Securities to be registered pursuant to Section 12(b) of the
Act:
|
Title of each class
to
be so registered
|
|
Name of each exchange on which
each class is to be
registered
|
|
Common Stock, par value $0.0001 per share
|
|
The
NASDAQ Stock Market LLC
|
If this
form relates to the registration of a class of securities pursuant
to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box. ☑
If this form relates to the registration of a
class of securities pursuant to Section 12(g) of the Exchange Act
and is effective pursuant to General Instruction A.(d), check the
following box.
☐
Securities
Act registration statement file number to which this form relates:
333-214724.
Securities
to be registered pursuant to Section 12(g) of the Act:
None
(Title
of class)
INFORMATION
REQUIRED IN REGISTRATION STATEMENT
Item
1. Description of Registrant’s Securities to be
Registered.
The
description of ENDRA Life Sciences Inc.’s (the
“Registrant”) common stock, par value $0.0001 per share
(the “Common Stock”), required by this Item is
contained in the Registrant’s Registration Statement on
Form S-1 (Registration No. 333-214724) initially filed with
the Securities and Exchange Commission on November 21, 2016, and as
subsequently amended (the “Registration Statement”),
under the caption “Description of the Securities We Are
Offering,” and is incorporated herein by reference. The
description of the Common Stock included in any form of prospectus
subsequently filed by the Registrant pursuant to Rule 424(b) under
the Securities Act of 1933, as amended, that constitutes a part of
the Registration Statement shall also be deemed to be incorporated
herein by reference.
Item
2. Exhibits.
Under
the Instructions as to Exhibits with respect to Form 8-A, no
exhibits are required to be filed because no other securities of
the Registrant are registered on The NASDAQ Stock Market LLC and
the securities registered hereby are not being registered pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as
amended.
SIGNATURE
Pursuant to the
requirements of Section 12 of the Securities Exchange Act of 1934,
the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized,
in the City of Ann Arbor, State of Michigan, on this 16th day of
December, 2016.
|
|
ENDRA LIFE SCIENCES
INC.
|
|
|
|
|
|
|
|
Date: December 16,
2016
|
By:
|
/s/
Francois
Michelon
|
|
|
|
|
Name:
Francois
Michelon
|
|
|
|
|
Title:
Chief
Executive Officer and Director
|
|